The Molecular Biology of Myeloma

David S. Siegel, MD, PhD

Video Categories: Targeted Therapies

Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.
October 1, 2014

Value of Specialty Pharmacy in Polycythemia Vera

Atheer Kaddis, SVP Sales/Business Development of Diplomat Specialty Pharmacy, describes in his opinion how specialty pharmacy can assist patients with polycythemia veraSupported through funding from Incyte

July 29, 2015

Discussing Cost and Value with Patients

Dr. Steve O’Day understands that cost is a major concern for patients and urges oncologists to discuss the “big picture” with their patients so that they understand the full value of a treatment.